1.
To screen or not to screen for albuminuria? Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of diabetic nephr...
2.
Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in the Netherlands - a Markov model